Skip to main content
Book cover

Vitiligo pp 177–180Cite as

Quality of Life

  • 681 Accesses

Abstract

Vitiligo can induce considerable psychosocial stress and psychiatric comorbidity. Then, it is important to recognize and manage the psychological component not only to improve coping but also to obtain a better treatment response.

The training in assertiveness, relaxation skills and help in building self-confidence would have substantial effects on quality of life as well as treatment outcomes. In fact, social and psychological well-being increase when patients with facial disfigurement are helped to develop social skills and to confront their difficulties. There is need for a standardized quality of life evaluation tool which can quantify the psychosocial stress of vitiligo subject and which could be used for treatment evaluation.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-62960-5_18
  • Chapter length: 4 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-3-319-62960-5
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Hardcover Book
USD   149.99
Price excludes VAT (USA)

References

  1. Bolognia JL, Pawelek JM. Biology of hypopigmentation. J Am Acad Dermatol. 1988;19:217–55.

    CAS  CrossRef  Google Scholar 

  2. Lerner AB. Vitiligo. J Invest Dermatol. 1959;32:285–310.

    CAS  CrossRef  Google Scholar 

  3. Lerner AB, Nordlund JJ. Vitiligo. What is it? Is it important? JAMA. 1978;239:1183–7.

    CAS  CrossRef  Google Scholar 

  4. Fitzpatrick TB. The scourge of vitiligo. Fitzpatrick’s J Clin Dermatol. 1993;1:68–9.

    Google Scholar 

  5. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58.

    CrossRef  Google Scholar 

  6. Porter JR, Beuf AH, Nordlund JJ, Lerner AB. Personal responses to vitiligo. Arch Dermatol. 1978;114:1348–85.

    CrossRef  Google Scholar 

  7. Porter JR, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders. A study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1:73–7.

    CAS  CrossRef  Google Scholar 

  8. Porter J, Beuf A, Lerner A, et al. The effect of vitiligo on sexual relationship. J Am Acad Dermatol. 1990;22:221–2.

    CAS  CrossRef  Google Scholar 

  9. Salzer B, Schallreuter K. Investigations of the personality structure in patients with vitiligo and a possible association with catecholamine metabolism. Dermatology. 1995;190:109–15.

    CAS  CrossRef  Google Scholar 

  10. Schmid-Ott G, Kunsebeck HW, Jecht E, Shimshoni R, et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol. 2007;21:456–61.

    CAS  PubMed  Google Scholar 

  11. Savin J. The hidden face of dermatology. Clin Exp Dermatol. 1993;18:393–5.

    CAS  CrossRef  Google Scholar 

  12. Mattoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16:573–8.

    CAS  CrossRef  Google Scholar 

  13. Ginsburg IH. The psychological impact of skin diseases: an overview. Dermatol Clin. 1996;14:473–84.

    CAS  CrossRef  Google Scholar 

  14. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 1997;137(2):246–50.

    CAS  CrossRef  Google Scholar 

  15. Hill-Beuf A, Porter JDR. Children coping with impared appearance. Social and psychologic influences. Gen Hosp Psychiatry. 1984;6:294–300.

    CAS  CrossRef  Google Scholar 

  16. Kent G, Al’ Abadie M. Factors affecting responses on dermatology life quality index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21:330–3.

    CAS  CrossRef  Google Scholar 

  17. Al’Abadie MSK, Kent G, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol. 1994;130:199–203.

    CrossRef  Google Scholar 

  18. Tu C, Zhao D, Lin X. Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo. J Dermatol Sci. 2001;27:178–82.

    CAS  CrossRef  Google Scholar 

  19. Liu PY, Bondesson L, Löntz W, Johansson O. The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study. Arch Dermatol Res. 1996;288:670–5.

    CAS  CrossRef  Google Scholar 

  20. Picardi A, Pasquini P, Cattaruzza MS, et al. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom. 2003;72:150–8.

    CAS  CrossRef  Google Scholar 

  21. Parsad D, Pandhi R, Dogra S, et al. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003;148:373–4.

    CAS  CrossRef  Google Scholar 

  22. Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S. Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo. Indian J Dermatol Venereol Leprol. 2013;79:205–10.

    CrossRef  Google Scholar 

  23. Gupta V, Sreenivas V, Mehta M, Khaitan BK, Ramam M. Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument. Br J Dermatol. 2014;171:1084–90.

    CAS  CrossRef  Google Scholar 

  24. Gupta V, Sreenivas V, Mehta M, Ramam M. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach. Br J Dermatol. 2018.

    Google Scholar 

  25. Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69:e11–8.

    CrossRef  Google Scholar 

  26. Catucci Boza J, Giongo N, Machado P, Horn R, Fabbrin A, Cestari T. Quality of life impairment in children and adults with vitiligo: a cross-sectional study based on dermatology-specific and disease-specific quality of life instruments. Dermatology. 2016;232:619–25.

    CrossRef  Google Scholar 

  27. Salzes C, Abadie S, Seneschal J, Whitton M, Meurant J-M, Jouary T, et al. The Vitiligo Impact Patient scale (VIPs): development and validation of a Vitiligo Burden Assessment Tool. J Invest Dermatol. 2016;136:52–8.

    CAS  CrossRef  Google Scholar 

  28. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behaviour therapy. Br J Med Psychol. 1999;72:385–96.

    CrossRef  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Bishnoi, A., Parsad, D. (2019). Quality of Life. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Cham. https://doi.org/10.1007/978-3-319-62960-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62960-5_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62958-2

  • Online ISBN: 978-3-319-62960-5

  • eBook Packages: MedicineMedicine (R0)